Hap Trading, LLC Protagonist Therapeutics, Inc Call Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023
BUY
$10.78 - $25.38 $235,004 - $553,284
21,800 New
21,800 $161,000
Q1 2022

May 12, 2022
SELL
$23.34 - $36.08 $830,904 - $1.28 Million
-35,600 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$17.63 - $37.1 $172,774 - $363,580
-9,800 Reduced 21.59%
35,600 $189,000
Q3 2021

Nov 10, 2021
BUY
$12.95 - $49.69 $587,930 - $2.26 Million
45,400 New
45,400 $56,000

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email